Acellular pertussis vaccine

Pertussis, acellular component of monovalent or combined vaccines

Title: Guidelines for the production and control of the acellular pertussis component of monovalent or combined vaccines; Adopted 1996, TRS no 878, Annex 2


  • WHO Implementation workshop of regulatory expectations and assessment of biotherapeutics in the Africa region, Accra, Ghana, 8-10 September 2015
  • Expert Committee on biological Standardization, WHO Headquarters, Geneva, Switzerland, 12-16 October 2015


Technologies Standards and Norms (TSN)
Essential Medicines and Health Products (EMP)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971